Please note that ANSA preferred method of payment is PayPal. For those who prefer not to use credit card there is an alternative option for payments: electronic funds transfer to ANSA Westpac account :BSB:034-234  account NO: 247319.

Please send email to secretary@appliedneuroscience.org.auto let us know your transaction reference, date and amount transfered.

Thank you for your cooperation.
______________________________________________________________

22-26 August 2019

Gateway to Health:  13th Annual Conference & Workshops

The Applied Neuroscience Society of Australasia is a membership organization comprised of health professionals who are involved in the promotion of better mental health. ANSA promotes education and professional excellence. Neuroscience technology is advancing to provide new insights into the workings of the brain and powerful neurofeedback applications provide direct modulation of brain states.  Research has shown that neurofeedback contributes to improved outcomes for a wide range of conditions including ADHD, autism, anxiety, depression, PTSD, mild traumatic brain injury, learning difficulties and sleep disturbances amongst others. With regular neurofeedback therapy and practice, significant improvements occur 70 – 80% of the time (Hammond et al, 2011).  ANSA members and other professionals interested in applied neuroscience, are invited to participate in our annual conference to be held in Cairns, gateway to the Great Barrier Reef. 

Early Bird registration NOW at Eventbrite

About our pre & post workshop Presenters:

DR. RONALD J. SWATZYNA is the Director of Electro-Neurophysiology Research and the Director of Neurotherapy at the Tarnow Center in Houston, Texas. For the past 20 years, Dr. Swatzyna has analyzed and treated the most diagnostically challenging cases in both inpatient and outpatient settings. As a researcher, he has presented and/or published over 70 peer-reviewed papers on brain dysfunction, psychotropic medication and other related topics at national and international conferences. In addition, Dr. Swatzyna is a Special Editor for WebmedCentral plus and Clinical EEG and Neuroscience. Prior to his career in mental health, Dr. Swatzyna served in both the Vietnam and the first Gulf War. Finally, his personal battle with a traumatic brain injury and PTSD has motivated him to become a leading expert in brain dysfunction.  In addition to a keynote address during the conference weekend, Dr Swatzyna will teach two workshops.

DAVE SIEVER graduated in 1978 as an engineering technologist who initially worked to design TMJ Dysfunction related diagnostic equipment and research facilities. Dave had noted anxiety issues in many patients suffering with TMJ dysfunction, prompting him to study biofeedback, which he applied to the patients and then later, Dave design biofeedback devices. In 1984, Dave designed his first audio-visual entrainment (AVE) device – the “Digital Audio-visual Integration Device,” or DAVID1. Through his company, Mind Alive Inc., Dave has been researching and refining AVE technology, specifically for use in relaxation, boosting academic performance and treating anxiety, depression, PMS, ADD, FMS, SAD, pain, cognitive decline and insomnia. Dave also designs Cranio-Electro Stimulation (CES) products and is a leading provider of transcranial DC stimulation (tDCS) and devices. As a result of Dave’s commitment to research, Mind Alive Inc now owns three patents involving neurotechnology. Dave continues to conduct research, perform a quantitative EEG service and designs new products pertaining to enhanced performance and mental wellness.   In addition to a keynote address during the conference weekend, Dave Siever will teach a 2-day workshop.

2-day Physiology & Clinical Outcomes with Brain Stimulation Technologies Workshop 22 & 23 August, presented by Dave Siever

ANSA MEMBER: $480; NON-member: $680

A 2-day didactic training in multi-modal brain stimulation: Much has been discovered about the benefits of brainwave entrainment (BWE) or audio-visual entrainment (AVE), as it is commonly known. AVE affects cerebral blood flow, neurotransmitters, dissociative states and brainwave activity. Research demonstrates the effectiveness of AVE in promoting relaxation, cognition and hypnotic induction, treating ADD, PMS, SAD, PTSD, migraine headache, chronic pain, anxiety, depression and episodic memory. Recent discoveries have shown AVE to be a powerful means of recovery from traumatic brain injuries of a newly discovered type - thalamocortical disconnect. Interest in cranio-electro stimulation (CES) was initiated by Robinovitch, who, in 1914 made the first claim for electrical treatment of insomnia. Most of the 200+ studies have shown CES as a reliable method to reduce anxiety, depression, pain, and to improve sleep and cognition function. Transcranial DC Stimulation (tDCS) has been extensively studied. A major advantage of tDCS is that it may be applied directly over an area of concern where the cortical activity on the brain may be enhanced or suppressed, much like neurofeedback. 1000+ studies on tDCS, including 100 on stroke rehabilitation, have been published.

1-day Pharmaco-EEG & Neuromodulation Workshop, Friday 23/08/19, presented by Ron Swatzyna

ANSA MEMBER: $280; NON-member: $380

Dr Swatzyna has used electroencephalography (EEG) and quantitative (qEEG) data to assist psychiatrists in medication selection and titration. He also holds the distinction of being the first in the US to integrate Pharmaco-EEG into private practice. For his publications and presentation in Pharmaco-EEG, he was admitted as an Affiliate Individual member into the World Psychiatric Association and is a committee member of the Psychiatric Electrophysiology Section. As a researcher, he has presented and/or published 70 peer-reviewed papers on brain dysfunction, psychotropic medication and other related topics.

1-day Mental Health Neurobiomarkers Workshop, Thursday 22/08/19, presented by Ron Swatzyna

ANSA MEMBER: $280; NON-member: $380

Mental health issues are diagnosed based on presenting symptoms, however, we now know that there can be many causes for those symptoms and the process of diagnosis has been called into question by the National Institute of Mental Health. In 2012, the Research Domain Criteria (RDoC) Project was instituted to generate scientific investigations to discover the links between biomarkers and the presenting psychiatric symptoms. In 2014 a study, using EEG and qEEG, identified four primary neuro-biomarkers that explained most psychiatric medication failure. In 2015 another study found only a 6.25% association between the diagnosis assigned and the neuro-biomarkers responsible for their symptoms. This data provides valuable information for medication selection and titration, treatment selection, and recommendations for additional testing referrals e.g., imaging, lab work, sleep studies. The treatment of mental health issues can now be based on science initiated by clinical research.

EARLY BIRD CONFERENCE WEEKEND, 24th & 25th August 2019

Pre-program launch special for all registrants - $480

This Conference Early Bird Registration rate represents fantastic value for 2 days of professional development to include keynote presentations by Ron Swatzyna and Dave Siever. Many other presenters are yet to be included in the program. This ticket price excludes any social events, yet to be announced. This ticket option will expire when the full program is launched in November so please register now!!  Member and Non-Member Conference Weekend Registration regular rates will be $580 and $680.

Register NOW at: https://www.eventbrite.com.au/e/2019-ansa-conference-workshops-gateway-to-health-tickets-48189068802  

ANSA 12th Annual Conference & Workshops in Brisbane, Australia, 16 - 20 August 2018

Conference & Workshop registration options now closed - Conference Handbook now here

__________________________________________________________________________________________

2018 CONFERENCE FREEBIE - Fantastic prerecorded keynote by Dave Siever (donating his fee to Aussie Farmers Appeal).

Transcranial DC Stimulation History, Physiology & Clinical Applications

Transcranial DC Stimulation (tDCS) is a neuro-stimulation technique used to enhance brain function by placing electrodes at specific locations on the scalp that represent functions in the brain, and then putting a small electrical current through the brain. There are currently 1200 studies showing tDCS is effective in improving academic performance, problem solving, math skills, musical ability as well as recovery from stroke, including sensori-motor issues and aphasias. TDCS has been successfully used to treat a wide variety of maladies, including depression, anxiety, substance abuse and closed-head injuries.

____________________________________________________________________________________________

With thanks to our 2018 Silver Sponsors: Neurotherapy Institute of Australia, Biomedical.com, OchsLabs Australasia, Institute of Functional Neuroscience, NovaTech EEG, Brain, Mind & Memory Institute, Medilink Australia, TALI Health , NeuroTech Solutions, and the neuroCare Group.

Workshops by EEG Education & Research - Silver Sponsor ANSA Conference 2018

The goal of our trainings is to produce competent neurofeedback practitioners. Such practitioners are able to integrate their understanding of symptom presentation, brain function and EEG into a coherent neurofeedback treatment strategy, and then monitor and adjust that strategy throughout treatment.

The 4-day Neurofeedback in a Clinical Practice  training course is the first step in that process. It will give clinicians the necessary basic skills and understanding to use neurofeedback equipment in a professional setting, applying eyes open neurofeedback protocols. Courses are offered throughout Australia. Please contact us for current schedule of events.

Telephone: 02 8268 8888 For more information, contact Dr Moshe Perl in Melbourne on Ph: +61 3 9533 0555 or visit the website at http://www.neurotherapy.com.au/index/Courses 

Workshops by NovaTech EEG - Silver Sponsor ANSA Conference 2018

BCIA and QEEG Certification Didactic Training Course

REGISTER: info@novatecheeg.com or +1 (480) 219-3048

Course Dates: tbc, please contact for forthcoming schedule of events

Course Times: 08:00- 18:00 daily
Course Location: tbc

Course Instructors: Leslie Sherlin PhD, CC-AASP, QEEGD, BCN, BCB; & Jon Hegg, MA Psych, BCN

Course Description:  Nova Tech EEG is an accredited training course for both BCIA and QEEG certification boards.  This 4 day training course satisfies the didactic requirements for both the Biofeedback Certification International Alliance neurofeedback blueprint and the QEEG Certification Board quantitative electroencephalography blueprint.

Workshops by STARTTS

Workshops are offered by STARTTS  in relation to the treatment of torture and trauma patients at various times throughout the year. Please check out their webpage for any upcoming workshops: http://www.startts.org.au/training/